Core Insights - Buenaventura Mining (BVN) is set to report its fourth-quarter 2025 results on February 26, with total sales expected to reach $447.6 million, reflecting a 49.4% increase year-over-year [1] - The consensus estimate for earnings per share remains at 59 cents, indicating a significant 354% increase from the same quarter last year [1] Financial Performance - The company has a trailing four-quarter earnings surprise average of 28.02%, having beaten estimates in three of the last four quarters [2][3] - The earnings estimates for the upcoming quarters have shown no revisions for Q1 and Q2, while F1 and F2 estimates have increased by 4.35% and 16.55% respectively [2] Production and Sales - In Q4 2025, gold production from direct operations was 35,151 ounces, down 11% year-over-year, while total gold production including Coimolache was 42,023 ounces, up 3% [8] - Silver production from direct operations was approximately 4.06 million ounces, reflecting a 2% year-over-year increase, with total silver production including Coimolache at 3.92 million ounces [9] - The company sold 39,452 ounces of gold in Q4 2025, marking a 3% increase year-over-year [8] Pricing Environment - Average realized gold prices surged 60% year-over-year to $4,214 per ounce, while silver prices averaged around $58.55 per ounce, up 88% year-over-year [10] - Copper prices increased by 27% year-over-year, with lead and zinc prices both rising by 3% [10] Stock Performance - Buenaventura Mining's shares have increased by 203.1% over the past year, compared to the industry's growth of 229.6% [11]

Core Insights - AvePoint (AVPT) is set to report its fourth-quarter 2025 results on February 26, with expected revenues between $110 million and $112 million, indicating a year-over-year growth of 23-26% [1][9] - The Zacks Consensus Estimate for fourth-quarter 2025 revenues is $111.11 million, suggesting a growth of 24.59% compared to the previous year [2] - For the full year 2025, AvePoint anticipates total revenues between $414.8 million and $416.8 million, representing a year-over-year growth of 25.5-26.1% [3] Revenue and Earnings Expectations - The company expects non-GAAP operating income for Q4 2025 to be between $21 million and $22 million [1] - The consensus estimate for fourth-quarter 2025 earnings is 9 cents per share, reflecting a significant year-over-year growth of 325% [2][4] - For the full year 2025, the consensus estimate for earnings is 33 cents per share, indicating a 22.22% growth year-over-year [4] SaaS Growth and Customer Acquisition - AvePoint's SaaS segment is expected to have continued its strong performance, with a reported growth of 38% year-over-year in Q3, making up 77% of total revenues [5][9] - The company added a record 41 new customers with annual recurring revenue (ARR) exceeding $100K, bringing the total to 762 customers by the end of Q3 [7] Retention Rates and Market Conditions - AvePoint reported a gross retention rate of 88% and a net retention rate of 110% for Q3 2025, with management aiming for long-term targets of 90% and 115% respectively [8] - The ongoing U.S. federal government shutdown may have impacted deal closures in Q4, contributing to uncertainty in revenue expectations [10] Earnings Prediction Model - Current analysis indicates that AvePoint does not have a conclusive prediction for an earnings beat, with an Earnings ESP of 0.00% and a Zacks Rank of 4 (Sell) [11]

Core Insights - Lululemon (LULU) is positioned to continue its earnings-beat streak, particularly in light of its recent performance in the Zacks Textile - Apparel industry [1] Earnings Performance - In the most recent quarter, Lululemon reported earnings of $2.59 per share, exceeding the expected $2.22 per share, resulting in a surprise of 16.67% [2] - For the previous quarter, the company reported $3.1 per share against an expectation of $2.84 per share, leading to a surprise of 9.15% [2] Earnings Estimates and Predictions - Estimates for Lululemon have been trending higher due to its history of earnings surprises, with a positive Zacks Earnings ESP of +1.22%, indicating bullish sentiment among analysts regarding its near-term earnings potential [5][8] - The combination of a positive Earnings ESP and a Zacks Rank 3 (Hold) suggests a high likelihood of another earnings beat, with historical data showing that stocks with this combination beat consensus estimates nearly 70% of the time [6][8] Importance of Earnings ESP - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions, which may be more accurate [7] - Monitoring a company's Earnings ESP before quarterly releases is crucial for increasing the odds of successful investment decisions [10]

Core Viewpoint - Oil States International (OIS) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Ratings - The Zacks rating system is based solely on a company's changing earnings picture, tracking the Zacks Consensus Estimate for EPS from sell-side analysts [2]. - The recent upgrade reflects an improvement in Oil States International's earnings outlook, which is expected to lead to increased buying pressure and a rise in stock price [4][6]. Impact of Earnings Estimates on Stock Prices - Changes in a company's future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with near-term stock price movements [5]. - Institutional investors utilize earnings estimates to determine the fair value of stocks, leading to significant buying or selling activity that affects stock prices [5]. Recent Performance of Oil States International - For the fiscal year ending December 2026, Oil States International is projected to earn $0.49 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 1% over the past three months [9]. Zacks Rank System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks which have averaged a +25% annual return since 1988 [8]. - The upgrade to Zacks Rank 2 places Oil States International in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10][11].

Core Insights - Coloplast A/S Sponsored ADR (CLPBY) is currently rated as a Buy (2) according to the Zacks Rank, while Penumbra (PEN) is rated as a Sell (4), indicating a more favorable earnings outlook for CLPBY [3] - Value investors utilize various traditional metrics to identify undervalued companies, including P/E ratio, P/S ratio, earnings yield, and cash flow per share [4] Valuation Metrics - CLPBY has a forward P/E ratio of 19.03, significantly lower than PEN's forward P/E of 67.01, suggesting that CLPBY may be undervalued [5] - The PEG ratio for CLPBY is 0.75, while PEN's PEG ratio is 2.09, indicating that CLPBY has a better balance between its price and expected earnings growth [5] - CLPBY's P/B ratio stands at 7.91 compared to PEN's 9.78, further supporting the argument that CLPBY is more attractively valued [6] Conclusion - Given the stronger estimate revision activity and more favorable valuation metrics, CLPBY is positioned as the superior investment option for value investors at this time [7]

Key Takeaways MARA is set to report Q4 2025 results on Feb. 26, after the bell.Zacks Consensus Estimate projects a $0.23 loss per share versus $1.24 earnings last year.Revenues are estimated at $224M, up 4.4% year over year.MARA Holdings, Inc. (MARA) is set to report fourth-quarter 2025 results on Feb. 26, after the bell.The Zacks Consensus Estimate for the bottom line is pegged at a loss of 23 cents per share compared with earnings of $1.24 in the year-ago quarter.MARA’s earnings have surpassed the Zacks C ...

Core Viewpoint - TXO Partners LP is anticipated to report a year-over-year decline in earnings despite an increase in revenues, which could significantly influence its stock price depending on the actual results compared to estimates [1][2]. Earnings Expectations - The upcoming earnings report is expected to show quarterly earnings of $0.10 per share, reflecting a year-over-year decrease of 61.5%. Revenues are projected to be $111.09 million, representing a 24.4% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 75% higher in the last 30 days, indicating a positive reassessment by analysts regarding the company's earnings prospects [4]. Earnings Surprise Prediction - The Most Accurate Estimate for TXO Partners LP is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +57.90%. This suggests a strong likelihood of beating the consensus EPS estimate, although the stock currently holds a Zacks Rank of 3 [12]. Historical Performance - In the last reported quarter, TXO Partners LP exceeded the expected earnings of $0.01 per share by delivering $0.08, resulting in a surprise of +700.00%. Over the past four quarters, the company has beaten consensus EPS estimates twice [13][14]. Conclusion - TXO Partners LP is viewed as a compelling candidate for an earnings beat, but investors are advised to consider additional factors beyond earnings expectations when making investment decisions [17].

Core Viewpoint - AeroVironment (AVAV) is anticipated to report a year-over-year increase in earnings and revenues for the quarter ended January 2026, with earnings expected at $0.70 per share, reflecting a +133.3% change, and revenues projected at $480.05 million, up 186.4% from the previous year [1][3]. Earnings Expectations - The stock may experience upward movement if the earnings report exceeds expectations, while a miss could lead to a decline [2]. - The management's discussion during the earnings call will significantly influence the sustainability of any immediate price changes and future earnings expectations [2]. Estimate Revisions - The consensus EPS estimate has been revised down by 3.38% over the last 30 days, indicating a reassessment by analysts regarding the company's earnings prospects [4]. - The Most Accurate Estimate for AeroVironment is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -9.13%, suggesting a bearish outlook from analysts [12]. Earnings Surprise History - In the last reported quarter, AeroVironment was expected to post earnings of $0.85 per share but only achieved $0.44, resulting in a surprise of -48.24% [13]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [14]. Bottom Line - An earnings beat or miss is not the sole determinant of stock movement, as other factors can influence investor sentiment [15]. - Despite the current outlook, AeroVironment does not appear to be a compelling candidate for an earnings beat, and investors should consider additional factors before making investment decisions [17].

Core Viewpoint - The market anticipates Esperion Therapeutics (ESPR) will report a year-over-year increase in earnings and revenues for the quarter ended December 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Esperion is expected to post quarterly earnings of $0.23 per share, reflecting a year-over-year increase of +330% [3]. - Revenues are projected to reach $160.58 million, which is a 132.4% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 58.82% higher in the last 30 days, indicating a positive reassessment by analysts [4]. - The Most Accurate Estimate for Esperion is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +37.63% [11]. Earnings Surprise Prediction - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [9]. - Esperion currently holds a Zacks Rank of 3, suggesting a likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Esperion was expected to post a loss of $0.09 per share but actually reported a loss of -$0.16, resulting in a surprise of -77.78% [12]. - Over the past four quarters, Esperion has beaten consensus EPS estimates two times [13]. Industry Comparison - Another company in the Zacks Medical - Drugs industry, Harrow (HROW), is expected to report earnings of $0.4 per share, indicating a year-over-year change of +60% [17]. - Harrow's consensus EPS estimate has been revised down by 666.7% over the last 30 days, and it currently has an Earnings ESP of -0.42% with a Zacks Rank of 4 (Sell) [18].

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for NeuroPace, Inc. due to higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - NeuroPace is expected to report a quarterly loss of $0.14 per share, reflecting a year-over-year change of +22.2% [3]. - Revenues are projected to be $25.95 million, which is an increase of 20.9% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 15.25% lower in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for NeuroPace aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12]. Earnings Surprise Prediction - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - NeuroPace currently holds a Zacks Rank of 4, making it challenging to predict an earnings beat [12]. Historical Performance - In the last reported quarter, NeuroPace was expected to post a loss of $0.20 per share but actually reported a loss of -$0.11, resulting in a surprise of +45.00% [13]. - Over the past four quarters, NeuroPace has beaten consensus EPS estimates three times [14]. Industry Comparison - Teleflex, another company in the Zacks Medical - Instruments industry, is expected to report an EPS of $3.73 for the same quarter, indicating a year-over-year change of -4.1% [18]. - Teleflex's revenues are expected to be $925.96 million, up 16.4% from the previous year, but it has a negative Earnings ESP of -2.70% [19][20].